| Journal | JMIR Research Protocols |
| Study Type | Cohort |
| Population | Human participants |
This represents the first rigorous prospective cohort study designed to track real-world medical marijuana use in older adults over time. With seniors becoming the fastest-growing cannabis patient population, we desperately need longitudinal data on both efficacy and safety outcomes in this vulnerable group.
The SMILE study is a prospective cohort protocol that will follow older adult medical marijuana patients longitudinally, examining effects on pain, cognitive function, physical and mental health, and quality of life. The study aims to identify which product characteristics and patient subgroups are associated with optimal outcomes versus adverse effects. This protocol paper outlines methodology rather than presenting results, but represents a significant step toward generating the evidence base clinicians need for this population. The real-world design will capture how patients actually use cannabis products rather than controlled experimental conditions.
“I’ve been waiting for exactly this type of study design – we treat older cannabis patients daily but have been flying blind on long-term outcomes. This protocol gives me hope we’ll finally have data to guide dosing, product selection, and safety monitoring in my senior patients.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Why is medical marijuana research specifically needed in older adults?
- What are the main concerns about medical marijuana use in elderly patients?
- What is the most common reason older adults use medical marijuana?
- How will this study help clinicians make better recommendations about medical marijuana?
- What makes this study design particularly valuable for clinical practice?
FAQ
Why is medical marijuana research specifically needed in older adults?
Older adults represent the fastest-growing group of medical marijuana users in the United States, yet scientific evidence remains limited regarding its effects on this population. This demographic may have unique responses to cannabis due to age-related changes in metabolism, concurrent medications, and different health priorities compared to younger users.
What are the main concerns about medical marijuana use in elderly patients?
Key concerns include potential impacts on cognitive function, which may already be compromised in older adults, and unknown long-term effects on physical and mental health. The SMILE study specifically aims to assess these critical outcomes to better inform clinical decision-making in geriatric populations.
What is the most common reason older adults use medical marijuana?
Chronic pain is the most common indication for medical marijuana use among older adults. This aligns with the high prevalence of chronic pain conditions in this age group and the challenges of managing pain with traditional medications that may have significant side effects or contraindications.
How will this study help clinicians make better recommendations about medical marijuana?
The SMILE study aims to identify specific medical marijuana product characteristics and patient subgroups associated with improved outcomes and side effects. This real-world evidence will help clinicians make more informed, personalized recommendations rather than relying on limited existing data.
What makes this study design particularly valuable for clinical practice?
This is a prospective cohort study that will examine real-world medical marijuana products over time, providing more clinically relevant data than controlled laboratory studies. The longitudinal design will capture both short-term and long-term effects, filling a critical evidence gap for clinical practice and public policy development.